Furthermore, loss of PTEN in brain metastatic tumor cells increased the expression of cytokine chemokine (C‐C motif) ligand 2 (CCL2), which promoted the development of brain metastatic tumor cells.31 The gene discussed is CCL2; the disease is neoplasm.